Advertisement
Research ArticleHematology Free access | 10.1172/JCI32312
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Grosse, J. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Braun, A. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Varga-Szabo, D. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Beyersdorf, N. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Schneider, B. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Zeitlmann, L. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Hanke, P. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Schropp, P. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Mühlstedt, S. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Zorn, C. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Huber, M. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Schmittwolf, C. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Jagla, W. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Yu, P. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Kerkau, T. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Schulze, H. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Nehls, M. in: JCI | PubMed | Google Scholar
1Ingenium Pharmaceuticals AG, Munich, Germany. 2Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, and 3Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany. 4Max Planck Institute for Immunobiology, Freiburg, Germany. 5Laboratory for Pediatric Molecular Biology, Charité, Berlin, Germany. 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Zinklesweg 10, 97078 Würzburg, Germany. Phone: 49-931-201-44060; Fax: 49-931-201-44068; E-mail: bernhard.nieswandt@virchow.uni-wuerzburg.de.
Find articles by Nieswandt, B. in: JCI | PubMed | Google Scholar
Published October 25, 2007 - More info
Changes in cytoplasmic Ca2+ levels regulate a variety of fundamental cellular functions in virtually all cells. In nonexcitable cells, a major pathway of Ca2+ entry involves receptor-mediated depletion of intracellular Ca2+ stores followed by the activation of store-operated calcium channels in the plasma membrane. We have established a mouse line expressing an activating EF hand motif mutant of stromal interaction molecule 1 (Stim1), an ER receptor recently identified as the Ca2+ sensor responsible for activation of Ca2+ release–activated (CRAC) channels in T cells, whose function in mammalian physiology is not well understood. Mice expressing mutant Stim1 had macrothrombocytopenia and an associated bleeding disorder. Basal intracellular Ca2+ levels were increased in platelets, which resulted in a preactivation state, a selective unresponsiveness to immunoreceptor tyrosine activation motif–coupled agonists, and increased platelet consumption. In contrast, basal Ca2+ levels, but not receptor-mediated responses, were affected in mutant T cells. These findings identify Stim1 as a central regulator of platelet function and suggest a cell type–specific activation or composition of the CRAC complex.